Related Experiment Video
Updated: Mar 10, 2026
07:09
The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
Published on: July 16, 2014
49.6K
Neuropathic and Myopathic Pain.
Anthony C Rodrigues1, Peter B Kang2
1Department of Pediatrics, Floating Hospital for Children at Tufts Medical Center, Boston, MA.
Seminars in Pediatric Neurology
|December 20, 2016
Summary
Understanding and treating childhood neuromuscular pain is improving with advances in genetics and neuroimmunology. New diagnostic tools and therapies will soon offer better relief for these complex conditions.
Area of Science:
- Pediatric Neurology
- Pain Management
- Neuromuscular Disorders
Background:
- Childhood pain syndromes of neuromuscular origin present unique challenges in diagnosis and management compared to adults.
- Pediatric patients' symptom description and disease presentation patterns differ, complicating assessment.
- Recent scientific and clinical advancements are improving care for children with these conditions.
Purpose of the Study:
- To highlight progress in the evaluation and management of childhood pain syndromes of neuromuscular origin.
- To discuss advancements in understanding genetic and neuroimmunological aspects of these diseases.
- To outline emerging diagnostic and therapeutic strategies for affected children.
Main Methods:
- Review of recent scientific and clinical knowledge in pediatric neuromuscular pain.
- Focus on genetic discoveries (e.g., Fabry disease, erythromelalgia) and neuroimmunological approaches.
- Examination of standardized treatment protocols (e.g., complex regional pain syndrome) and ongoing research into metabolic muscle diseases.
Main Results:
- Improved understanding of genetic origins for conditions like Fabry disease and inherited erythromelalgia.
- Development of more sophisticated diagnostic and therapeutic approaches driven by neuroimmunology.
- Standardization of treatment protocols for complex regional pain syndrome.
- Ongoing investigations into novel interventions for metabolic muscle diseases like McArdle disease and carnitine palmitoyl transferase deficiency type II.
Conclusions:
- Significant progress is being made in the care of children with neuromuscular pain syndromes.
- Future years promise more precise diagnostic tools and novel therapies for these distressing conditions.
- Advancements in genetics, neuroimmunology, and treatment protocols are enhancing pediatric pain management.
Related Concept Videos
01:25Analgesia and Pain Management
2.6K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.6K
01:44Nociception
33.6K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
33.6K
01:20Pain
1.7K
Pain serves as a critical warning signal that alerts the body to potential or actual harm. When mechanical pressure on the skin is intense, such as from a sharp pinch, the sensation transitions from touch to pain. Similarly, extreme temperatures, like a hot pot handle, convert the sensation of heat into pain. Pain can also result from overstimulation of other senses, such as blinding light, loud noise, or the intense heat from habañero peppers. This ability to sense pain is essential for...
1.7K
01:24Local Anesthetics: Differential Sensitivity of Nerve Fibers
1.6K
Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...
1.6K
01:22Opioid Receptors: Overview
5.7K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
5.7K
01:29Neuromuscular Junction And Blockade
5.5K
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
5.5K